Original title: The Romanian Competition Authority fines EUR 22.6 M distributors and manufacturer for sharing insulin portfolio (Eli Lilly / A&A Medical / Mediplus Exim / Relad Pharma)
Source: Concurrence Bulletin, 2009
Register for free and get notified on the latest articles, documentation and publications.